News
Ultrasound ablation for Parkinson’s disease: Benefit limited by adverse effects
- Author:
- Sue Hughes
“Longer-term and larger trials are needed to determine the role of focused ultrasound subthalamotomy in the management of Parkinson’s disease.”
News
Which imaging criteria identify progressive forms of MS?
- Author:
- Sue Hughes
Identification of imaging features associated with primary progressive MS and features that predict evolution from relapsing-remitting MS to...
News
COVID-19 anticoagulation trials ‘paused’ for futility, safety
- Author:
- Sue Hughes
The trials involved are the REMAP-CAP, ACTIV-4, and ATTACC studies.
News

Disabling stroke reduced with ticagrelor after minor stroke, TIA
- Author:
- Sue Hughes
“This new information on disabling stroke underlines the importance of getting patients on dual antiplatelet therapy quickly after a TIA or mild...
News
Air pollution linked to brain amyloid pathology
- Author:
- Sue Hughes
Exposure to air pollution should be considered as one factor in the lifetime risk of developing Alzheimer’s disease.
News

COVID-19 and risk of clotting: ‘Be proactive about prevention’
- Author:
- Sue Hughes
"We believe a systematic way of addressing this risk is best, with every patient hospitalized with COVID-19 receiving some type of...
News

STRENGTH trial questions CV benefit of high-dose omega-3s
- Author:
- Sue Hughes
Questions about the CV benefit of omega-3 fatty acids and the high-dose eicosapentaenoic acid product, Vascepa, have resurfaced with results of...
News

SCAPIS: Simple questionnaire can identify silent atherosclerosis
- Author:
- Sue Hughes
The study found 40% of the middle-aged Swedish population without known heart disease had coronary plaques on CCTA, and those with extensive...
News

Local hospitals still have a role in treating severe stroke
- Author:
- Sue Hughes
Local centers performed very well in the study, with very fast “in/out” times for patients who were subsequently transferred for thrombectomy.
News

NfL blood biomarker captures suboptimal treatment response in MS
- Author:
- Sue Hughes
“Our data in this well-characterized large real-world cohort supports the value of serum NfL levels for treatment monitoring in MS clinical...
News
A skin test for Parkinson’s disease diagnosis?
- Author:
- Sue Hughes
The preliminary study used a chemical assay to detect clumping of alpha-synuclein in autopsy skin samples taken from patients who had Parkinson’s...
News
COVID-19 diagnosed on CTA scan in stroke patients
- Author:
- Sue Hughes
“As part of the stroke evaluation workup process, we were able to diagnose COVID-19 at the same time at no extra...
News
COVID-19: Thromboembolic events high despite prophylaxis
- Author:
- Sue Hughes
“Standard prophylaxis as recommended in the guidelines is a low dose of low-molecular-weight...
News
COVID-19 risks are no higher in patients with multiple sclerosis
- Author:
- Sue Hughes
MS does not appear to be associated with higher risks of severe COVID-19 outcomes compared with the general population.
News
Lower rituximab doses may be as effective, safer in MS
- Author:
- Sue Hughes
Adverse effects – particularly frequency of infection – were increased in the high-dose group.